A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A single center, randomized, doubled-blind, placebo-control and single ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of LY-CovMab Injection in Chinese healthy subjects.
Epistemonikos ID: 8c106a1d90efdae43eeae6c6b0246f2538010bd7
First added on: Jul 23, 2021